Instituto de Oncología de Rosario ( Site 0003)

Rosario, Santa Fe Province S2000KZE

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Non Small Cell Lung Cancer

Studies at this site

• Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002) — Completed